Bath & Body Works (NYSE:BBWI) Releases FY26 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its FY26 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.25-360 for the period, compared to the consensus estimate of $3.61. Bath & Body Works also updated its Q1 guidance to $0.36-0.43 EPS.

Wall Street Analyst Weigh In

Several equities research analysts have commented on BBWI shares. TD Cowen upped their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Cowen restated a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Barclays reduced their target price on Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating on the stock in a report on Monday, March 3rd. Robert W. Baird increased their price target on Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a report on Friday, February 28th. Finally, Argus reiterated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $45.06.

Bath & Body Works Stock Down 6.6 %

Shares of BBWI opened at $30.45 on Tuesday. The company has a 50 day moving average of $37.09 and a 200-day moving average of $34.14. The stock has a market capitalization of $6.60 billion, a P/E ratio of 7.43, a P/E/G ratio of 0.92 and a beta of 1.89. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. On average, sell-side analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.63%. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works declared that its board has authorized a stock buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s leadership believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.